Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section (NCT07511491) | Clinical Trial Compass
RecruitingNot Applicable
Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section
Egypt90 participantsStarted 2026-04-11
Plain-language summary
This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in cesarean section (CS).
Who can participate
Age range18 Years – 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age from 18 to 40 years.
* American Society of Anesthesiology (ASA) physical status II.
* Parturient women undergoing cesarean section under spinal anesthesia.
Exclusion Criteria:
* Parturient women with any contraindication or hypersensitivity to the study drugs.
* Any history of cardiovascular diseases, psychosis, hypertension, fetal distress, cord prolapse initial.
* Preoperative shivering.
* Preoperative fever (\>38°C).
* Body mass index \> 40 kg/m2.
* Medical history of alcohol or drug abuse.
* Hypo- or hyperthyroidism.
* Parkinson's disease or any extrapyramidal disease.
* Intraoperative blood transfusion.